Basic Information
Basic information for AL022068.1-217-32aa
Peptide Name AL022068.1-217-32aa
Genome Position chr6:19362401-19362496[-]
Species Human
Peptide Sequence MICRRSYSPLPWSCKRGWPWTWRSSGVESGRA
Peptide Length 32
Unique No (AL022068.1-224-32aa)
Grand Average of Hydropathicity -0.7844
Relative Molecular Mass 4342.8
Experimental Evidences no
lncRNA ID/Name ENSG00000228412;AL022068.1
Transcript ID/Name ENST00000660410;AL022068.1-217
Transcript Length 1469
Coding Ability 0.5636
DNA Sequence Corresponding to Peptide ATGATCTGCAGAAGAAGCTACTCTCCTTTGCCATGGAGCTGCAAACGTGGCTGGCCCTGGACTTGGAGAAGCTCCGGAGTGGAATCTGGCAGGGCC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :